Vimarsana.com

Latest Breaking News On - Travis mickle - Page 1 : vimarsana.com

Zevra Therapeutics (ZVRA) Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors

Zevra Therapeutics (ZVRA) Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
France
French
Wendyl-dixon
Matthewr-plooster
Wendy-dixon
Travisc-mickle
Travis-mickle
Bristol-myers-squibb
Chris-posner

Zevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors

Zevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
France
French
Travisc-mickle
Wendyl-dixon
Bristol-myers-squibb
Travis-mickle
Nichol-ochsner
Jennifer-arcure
Chris-posner

KemPharm Appoints New Leadership - Global Genes

KemPharm Appoints New Leadership - Global Genes
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Germany
German
Travis-mickle
Matthew-plooster
Richard-pascoe
Joshua-schafer
Mallinckrodt-pharmaceuticals
Astellas-pharmaceuticals
Takeda-pharmaceuticals
University-of-notre-dame
Cognia-corporation
Accenture

KemPharm Gets FDA Orphan Drug Designation for Serdexmethylphenidate for Idiopathic Hypersomnia

The FDA has granted the Orphan Drug Designation to serdexmethylphenidate, KemPharm’s proprietary prodrug of d-methylphenidate for the treatment of idiopathic hypersomnia

United-states
Travis-mickle
Drug-administration
Orphan-drug-designation
Drug-designation

Serdexmethylphenidate Granted Orphan Drug Status for Idiopathic Hypersomnia

The FDA has granted Orphan Drug designation to serdexmethylphenidate (KP1077) for the treatment of idiopathic hypersomnia.

Travis-mickle
Drug-administration
Orphan-drug

vimarsana © 2020. All Rights Reserved.